Author

K. S. Yount

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. R. Fullen· 2 shared K. N. Corps· 2 shared P. Dubey· 2 shared R. Deora· 2 shared A. Kollipara· 1 shared C. B. Bagwell· 1 shared C. F. Love· 1 shared C. Liu· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. R. Fullen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Unique T cell signatures associated with reduced Chlamydia trachomatis reinfection in a highly exposed cohort

K. S. Yount, C.-J. Chen, A. Kollipara, C. Liu, N. V. Mokashi, X. Zheng, C. B. Bagwell, T. B. Poston, H. C. Wiesenfeld, S. L. Hillier, C. M. O'Connell, N. Stanley, T. Darville

This study identifies T cell signatures associated with reduced Chlamydia trachomatis reinfection in a highly exposed cohort using mass cytometry and random forest analysis.

bioRxiv · Aug 2, 2023 · PreprintImmunology

Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogen.

A. R. Fullen, J. L. Gutierrez-Ferman, K. S. Yount, C. F. Love, H. G. Choi, M. A. Vargas, D. Raju, K. N. Corps, P. L. Howell, P. Dubey, R. Deora

bioRxiv · Apr 6, 2022Microbiology

Bordetella Colonization Factor A (BcfA) elicits protective immunity against Bordetella bronchiseptica in the absence of an additional adjuvant

K. S. Yount, J. Jennings-Gee, K. Caution, A. R. Fullen, K. N. Corps, S. Quataert, R. Deora, P. Dubey

This study shows that BcfA can act as both an antigen and adjuvant, providing protection against B. bronchiseptica without additional adjuvants.

bioRxiv · Jul 4, 2019Immunology